EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin 15 (IL15)-based near-infrared photoimmunotherapy

Motofumi Suzuki iD, Aki Furusawa iD, Hiroshi Yamamoto, Makoto Kano, Miyu Kano, Seiichiro Takao iD, Shuhei Okuyama, Peter L Choyke iD, Hisataka Kobayashi iD

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-04151-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Motofumi Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD, 20892,…. Hauptthemen laut MEDLINE: Immunotherapy, Interleukin-15, Phototherapy, Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CCR NIH HHS, Center for Cancer Research, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective cancer therapy based on a targeted monoclonal antibody conjugated to phthalocyanine-based photoabsorber, IRDye700DX (IR700). Following injection, near-infrared light activates the conjugate causing direct cytotoxicity and immunogenic cell death. The high selectivity of NIR-PIT is traditionally based on the binding of a monoclonal antibody to its target thus bringing the photoabsorber, IR700, in close proximity to the cell membrane at the time of light exposure. However, other targeting moieties can be used and in the current study, interleukin-15 (IL15) is conjugated with IR700 to enable NIR-PIT. IL15-IR700 quickly bound to the cellular membrane of MC38 HIL15Rα cells that are transfected with human IL15 receptor alpha. NIR-PIT induced characteristic morphological changes accompanied by a significant decrease of cellular viability. Intratumoral injection of IL15-IR700 resulted in longer retention of the conjugate in the tumor compared to the intravenous injection. NIR-PIT with intratumoral IL15-IR700 significantly suppressed tumor growth, induced necrosis-like changes in tumor tissue, and stimulated host immune response. This study revealed that cytokine-based NIR-PIT is a potential therapeutic strategy for treating solid cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyInterleukin-15PhototherapyNeoplasmsAnimalsHumansMiceInfrared RaysCell Line, TumorFemaleMice, Inbred BALB CXenograft Model Antitumor AssaysIndolesIsoindolesAntibodies, Monoclonal

Stichwörter der Autor:innen

Immunogenic cell deathInterleukin-15Near-infrared photoimmunotherapyTumor treatment

Substanzen

Interleukin-15IndolesIsoindolesAntibodies, Monoclonal

Autor:innen und Institutionen

  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD, 20892, USA.
  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD, 20892, USA. kobayash@mail.nih.gov.

ORCID-Profile: Motofumi Suzuki, Aki Furusawa, Seiichiro Takao, Peter L Choyke, Hisataka Kobayashi

Förderung

  • CCR NIH HHS
  • Center for Cancer Research
  • National Cancer Institute

Zitieren

APA

Suzuki, M., Furusawa, A., Yamamoto, H., Kano, M., Kano, M., Takao, S., Okuyama, S., Choyke, P. L., & Kobayashi, H. (2025). Interleukin 15 (IL15)-based near-infrared photoimmunotherapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04151-8

Vancouver

Suzuki M, Furusawa A, Yamamoto H, Kano M, Kano M, Takao S, et al. Interleukin 15 (IL15)-based near-infrared photoimmunotherapy. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04151-8

BibTeX
@article{Suzuki2025,
  author = {Suzuki, Motofumi and Furusawa, Aki and Yamamoto, Hiroshi and Kano, Makoto and Kano, Miyu and Takao, Seiichiro and Okuyama, Shuhei and Choyke, Peter L and Kobayashi, Hisataka},
  title = {Interleukin 15 (IL15)-based near-infrared photoimmunotherapy},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-04151-8}
}
Kostenlos starten →